Cancer Cures

Acai Berry Concentrate 90 Caps $9.89 antioxidant Supports Heart and Circulatory Health improves energy good for the eyes regulates cholesterol improves digestion good for the skin anti inflammatory contains resveratrol contains polyphenols protect the brain contains omega 3 lowers histamine levels for allergies cures erectile dysfunction anti cancer anti tumor contains copper magnesium and phosphorus which fight free radicals good for weight loss contains phytochemicals which fight aging regulates nervous system
Benefits of Acai, One of the Top Fruits from the Amazon

Activated charcoal Helps Digestion,Treats Hangovers, cures Bug bites of all sorts Mosquitoes, horse flies and bees, It Whitens Teeth  strengthen Hair absorbs oders  Exfoliates The Skin Cleans Hair Filters Water effective at removing toxins derived from urea, the main byproduct of protein digestion, improves kidney

Alpha ketogletorate activates oct4 sox2 & klf4 genes which rejuvenate cells usually only turned on as embryos AKG increases lifespan by 18% in mice 8 years in humans AKG is crucial for the krebs cycle AKG as a precursor of glutamate & glutamine is a central metabolic fuel for cells of the gastrointestinal tract as well. AKG can decrease protein catabolism & increase protein synthesis to enhance bone tissue formation in the skeletal muscles & can be used in clinical applications. AkG is an endogenous metabolite acts as a fuel for mitochondria a substrate for 1000 different reaction in the body levels of AkG go down with age AKG reduces frailty by 50% improves adult stem cell function preserves melanocytes turns black grey hair AKG regulates cellular energy status through inhibiting adenosine triphosphate synthase and reducing oxygen consumption in mammalian and Caenorhabditis elegans cells [7]. AKG has also been reported to improve the energy status of the intestinal mucosa in lipopolysaccharide (LPS)-challenged pigs increases lifespan by reducing the level of systemic inflammatory cytokines & inducing anti-inflammatory cytokine IL-10

Aluminum blend with the kidisle 1200w blender from Amazon
Aluminum blend

Antineoplaston peptides Dr. Burzynski, a nationally and internationally recognized physician/investigator, pioneered the use of biologically active peptides for the treatment of cancer. In 1967, at the age of 24, Dr. Burzynski graduated first in his class of 250 students from the Medical Academy in Lublin, Poland. It was at this time that he identified naturally occurring human peptides, which were deficient in cancer patients. He concluded that these peptides played a role in preventing the growth of cancer cells. In 1968, he earned a PhD degree and became one of the youngest physician/investigators in Poland to hold both a MD and PhD degree.

Between 1970 and 1977, he received funding from the National Cancer Institute (NCI) for his work as a Principal investigator and Assistant Professor at the Baylor College of Medicine in Houston, TX. During this time he authored/coauthored numerous publications, including those detailing his work on naturally occurring human peptides and their effect on cancer – some of which were co-authored by investigators associated with the M.D. Anderson Cancer Center or the Baylor College School of Medicine. In May 1977, Dr. Burzynski received a Certificate of Appreciation from the Baylor College of Medicine that acknowledged his contributions to the ‘Advancement of Medical Education, Research, and Health Care’.

In 1977 the Burzynski Clinic was established in Houston, TX. Since then, more than 10,000 patients have received treatment at the clinic, including more than 2,300 cancer patients who have been treated in FDA reviewed and Institutional Review Board (IRB) approved clinical trials program of Antineoplastons, investigational agents that derived from Dr. Burzynski’s early investigations of naturally occurring human peptides. Currently, new FDA-reviewed Phase II and III clinical studies utilizing Antineoplastons are awaiting funding approval prior to patient enrollment.
proven Cancer Treatment | Burzynski Clinic | Cancer Therapy | Documentary

A0H1996 cancer cures are with us Psalms 103:1 A Psalm of David Bless the LORD, O my soul: and all that is within me, bless his holy name. The Phase 1 clinical trial tests the safety of providing City of Hope-developed AOH1996 to people with reoccurring solid tumors. LOS ANGELES — City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced that the first patient to receive its novel, promising cancer medicine AOH1996 is doing well. The Phase 1 clinical trial testing the safety of a potentially cancer-stopping therapeutic developed by City of Hope in people with reoccurring solid tumors is expected to continue for the next two years. The investigational pill has been effective in preclinical research treating cells derived from breast, prostate, brain, ovarian, cervical, skin and lung cancers. Linda Malkas, Ph.D., professor in City of Hope’s Department of Molecular Diagnostics & Experimental Therapeutics, has been working on the research and subsequent discovery and development of AOH1996 for 20 years. AOH1996 is named after Anna Olivia Healey, a young girl born in 1996 who unfortunately was not able to beat cancer. AOH1996 is exclusively licensed by City of Hope to RLL, LLC, a biotechnology company that Malkas co-founded.

Malkas believed that proliferating cell nuclear antigen (PCNA), which plays an essential role in the replication and repair of cells, would be a less toxic cancer therapy that targets mutated cancer cells while leaving normal cells alone. The treatment has been shown in preclinical research to target PCNA and inhibit the growth and spread of a broad range of human cancer cells. The research protocol notes that AOH1996 is not toxic to healthy cells as chemotherapy is and that treatment with this medicine both pauses cell DNA synthesis and inhibits DNA repair, leading to a type of cell death known as apoptosis in the cancer cells. “Imagine cancer as the water filling up a bathtub. Left unchecked, the tumors or water will eventually overflow and damage other parts of your home. The treatment my team at City of Hope created is akin to a watchful homeowner who shuts the water off — stopping the spread of tumors to other parts of the metaphorical house — and then drains the tub, eliminating the cancer,” said Malkas, co-investigator in the trial and the M.T. & B.A. Ahmadinia Professor in Molecular Oncology.

Vincent Chung, M.D., added, “By targeting PCNA, we are inhibiting the complex machinery to stop cellular growth and proliferation. This is a new way of trying to kill cancer cells or at least to slow it down.” He is a research professor in City of Hope’s Department of Medical Oncology & Therapeutics Research and principal investigator in the clinical trial.The Phase 1 clinical trial is open at City of Hope Los Angeles. Its objective is to determine the maximum tolerated dose of the investigational pill, AOH1996, and to evaluate the medicine for preliminary efficacy. Eligible patients include adults with solid tumors who have not found standard treatments effective. Participating patients will be asked to take the medication in pill form twice a day. “Since many patients’ cancers become resistant to our standard therapies, we need new therapeutics with new mechanisms of action — for example, non-cross resistant. AOH1996 is just that kind of new therapy,” said Daniel Von Hoff, M.D., of the Molecular Medicine Division at the Translational Genomics Research Institute, part of City of Hope, and an advisor on the study. “Congratulations to Dr. Malkas and the City of Hope team on this new invention.”

Malkas said other targeted therapies, like checkpoint inhibitors, that inhibit the growth and spread of cancer have helped innumerable cancer patients, adding that perhaps one day AOH1996 will be a U.S. Food and Drug Administration-approved inhibitor that could be used in combination with existing therapies to both enhance cancer-killing effects as well as decrease side effects related to lifesaving cancer treatments.With the infrastructure and support of City of Hope, Malkas was able to commercialize her basic research, moving her promising laboratory discovery into a clinical trial for people who need the therapies of tomorrow today. City of Hope provided structure, experts and even GMP (good manufacturing practice) facilities to manufacture her medicine. City of Hope is devoted to supporting research and development and has infrastructure that is tailor-made to accelerate innovations from the lab to patients. This system includes everything ranging from funding support to access to counsel from internal and external drug development specialists. City of Hope's R&D apparatus leverages the combination of its fundamental strength in basic science and its patient-care focus as a comprehensive cancer center. Individuals interested in this clinical trial should review the eligibility requirements at If they believe they are eligible, they can call 626-218-1133 or visit City of Hope’s clinical trials webpage. 

City of Hope's mission is to deliver the cures of tomorrow to the people who need them today. Founded in 1913, City of Hope has grown into one of the largest cancer research and treatment organizations in the U.S. and one of the leading research centers for diabetes and other life-threatening illnesses. As an independent, National Cancer Institute-designated comprehensive cancer center, City of Hope brings a uniquely integrated model to patients, spanning cancer care, research and development, academics and training, and innovation initiatives. Research and technology developed at City of Hope has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. A leader in bone marrow transplantation and immunotherapy, such as CAR T cell therapy, City of Hope’s personalized treatment protocols help advance cancer care throughout the world. With a goal of expanding access to the latest discoveries and leading-edge care to more patients, families and communities, City of Hope’s growing national system includes its main Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and Cancer Treatment Centers of America. City of Hope’s affiliated family of organizations includes Translational Genomics Research Institute and AccessHopeTM.

Apigenin antiviral inhibits CD38 enzyme CD38 degrades NAD+ levels Apigenin may induce muscle relaxation & sedation depending on the dose, & it is also active as an antioxidant, anti-inflammatory, anti-amyloidogenic, neuroprotective, and cognition-enhancing substance with interesting potential in the treatment/prevention of Alzheimer's disease. increases muscle mass, there is about 2.15 mg of apigenin in 1 gram of Parsley . Moreover, apigenin elongates survival in fly models of neurodegenerative disease and apigenin glycosides increase lifespan in worms. Apigenin's therapeutic potential is underscored by human clinical studies using chamomile extract, which contains apigenin as an active ingredient . Apigenin glycosides from green pepper enhance longevity & stress resistance in Caenorhabditis elegans , treatment could regulate the expression of anti-aging related genes, including daf-2, daf-16, sod-3, hsp-16.2, skn-1, gst-4, gcs-1, jnk-1, and sir-2.1 in C elegans, thereby promoting the translocation of DAF-16 and SKN-1 into the nucleus. treatment significantly reduced ROS under normal and stress conditions

Astaxanthin is an immune System Support. Astaxanthin helps to activate white blood cells (T-cells) and natural killer (NK) cells. Reducing Inflammation. Protects from UV Skin Damage. Supports Cognitive Health & muscle endurance as with migrating salmon which eat a lot of astaxanthin. From red colored seafood, salmon get their red color from astaxanthin, astaxanthin is an antioxidant. This protects cells from damage. Astaxanthin also improves salmon fish pregnancy by way of immune system functions. People use astaxanthin for many purposes, including Alzheimer disease, athletic performance, aging skin, muscle soreness from exercise, and many others. Carotenoid H Pluvialis create astaxanthin the most potent free radical scavenger 110x stronger than vitamin E 560x greater than green tea catechins 800x better than Coq10 Astaxanthin outperforms CoQ10 800 times over in fighting free radicals. CoQ10 has a wide variety of health benefits, including heart health, skin health, fertility, exercise performance, and cognitive function. Astaxanthin is 3000x more efficient than Resveratrol 6000x vitamin c . Astaxanthin increases the lifespan of lab tested mice by %12 4 mg = 8 servings of king Salmon everyday i'm as a salmon which cannot live without Astaxanthin artificial , supplement or algae based Astaxanthin
Astaxanthin unboxing
Ep. 9 - Astaxanthin Uncovered: Nature's Most Potent Secret with Dr. Karen Hecht
Astaxanthin - One of the secrets to Japanese longevity and beauty